Purpose Previous studies assessing racial and ethnic differences in ovarian cancer (OVCA) diagnosis stage fail to present subtype-specific results and provide historic data on cases diagnosed between 10 and 20 years ago. The purpose of this analysis is to assess non-Hispanic Black (NHB) and non-Hispanic White (NHW) differences in late-stage diagnosis including; (1) factors associated with late-stage diagnosis of invasive epithelial OVCA overall and by histologic subtypes, (2) potential changes across time and (3) current patterns of trends in a national cancer registry in the USA and Puerto Rico between 1998 and 2011. Methods NHB and NHW OVCA cases were derived from the National Cancer Database (NCDB). Diagnosis stage was analyzed as a dichotomous and a four level-category variable, respectively; early (stages I and II; localized) versus late (stages III and IV; regional and distant) and stages I, II, III and IV. Diagnosis period was trichotomized (1998-2002, 2003-2007, 2008-2011). Racial differences in stage were tested using Chi-square statistics. Odds ratios (OR) and 95 % confidence intervals (95 % CI) were estimated using multivariable binomial and generalized ordered logistic regressions. Interactions between race and diagnosis period were evaluated. Results Between 1998 and 2011, 11,562 (7.8 %) NHB and 137,106 (92.2 %) NHW were diagnosed with OVCA. In adjusted models, NHB were significantly more likely diagnosed with late-stage OVCA than NHW (OR adj 1.26, 95 % CI 1.19-1.33). Interaction between race and diagnosis period was marginally significant (p value = 0.09), with racial differences in stage decreasing over time (1998 -2007 1.27, 95 % CI 1.15-1.39; OR adj 1.15, 95 % CI 1.05-1.27). NHB were also more likely to be diagnosed with stage 4 high-grade serous (OR adj 1.46, 95 % CI 1.22-1.74), clear cell (OR adj 2.71, 95 % CI 1.94-3.79) and mucinous (OR adj 2.78, 95 % CI 2.24-3.46) carcinomas than NHW. Conclusions Racial differences in late-stage OVCA diagnosis exist; however, these differences are decreasing with time. Within NCDB, NHB are significantly more likely diagnosed with late-stage OVCA and more specifically high-grade serous, clear cell and mucinous carcinomas than NHW.
Purpose
In the USA, ovarian cancer (OVCA) is the eighth most commonly diagnosed cancer and the fifth leading cause of female cancer deaths [1] . The American Cancer Society (ACS) estimates that in 2015, 21 ,290 women will be diagnosed with OVCA and 14,180 will die from the disease [2] . One important reason for such a high mortality is the absence of an effective screening mechanism [3] . Together with the lack of screening, an absence of OVCA-specific symptoms leads to the detection of the disease at an advanced stage [Federation of Gynecology and Obstetrics (FIGO) stage III, IV] in approximately 70 % of women [4, 5] . Late-stage tumors have worse outcomes with a 5-year relative survival rates for stages I, II, III and IV of 90, 70, 39 and 17 %, respectively [1] . The high-grade serous carcinoma is the most common and the most lethal subtype of OVCA [6] . Less than 5 % of women diagnosed with high-grade serous carcinomas are diagnosed at stage 1 [7, 8] .
In the USA, OVCA incidence rates are higher in nonHispanic whites (NHW) than non-Hispanic blacks (NHB) [9] . The Centers for Disease Control and Prevention (CDC) estimates the 2012 age-adjusted incidence rates for whites at 11.6/100,000 women, compared to 9.3/100,000 for blacks [10] . However, the 5-year survival rate for blacks is 36 % compared to 44 % for whites (data were not reported for NHB/NHW) [11] . Racial differences in diagnosis stage may partly account for the survival disadvantage in NHB.
Previous studies assessing racial and ethnic differences in OVCA diagnosis stage fail to present results for various OVCA subtypes and provide historic data on cases diagnosed between 10 and 20 years ago [11] [12] [13] [14] [15] . Evidence suggests mixed historical study findings between race/ ethnicity and OVCA diagnosis stage may be due in part to challenges related to the nature of the data (e.g., small and regional samples, short time frames) [11] [12] [13] [14] [15] . Given the National Cancer Data Base (NCDB) includes approximately 70 % of OVCA cases and particularly data across 15 years, an up-to-date analysis including patterns of temporal trends for OVCA in general and by histologic subtypes is warranted. Temporal trends may provide a more definitive understanding and explanation for the inconclusive historical results for the relationship between race/ethnicity and OVCA diagnosis stage. The recent National Academy of Medicine report identified a need to perform subtype-specific analyses due to the heterogeneity of ovarian cancers [6] . Subtype-specific analyses may help identify the drivers for the potential disparities. To the best of our knowledge, subtype-specific temporal trends for OVCA have not been assessed in the past. The purpose of this analysis is to assess NHB and NHW differences in late-stage diagnosis of invasive epithelial OVCA overall and by histologic subtypes including: (1) current patterns of national trends, (2) potential changes across time and (3) factors associated with late-stage diagnosis in the USA and Puerto Rico between 1998 and 2011.
Methods

Study population
The NCDB is a joint project of the Commission on Cancer (CoC) of the American College of Surgeons and the ACS. Cases reported to NCDB represent approximately 70 % or more than 194,000 newly diagnosed OVCA cases in the USA and Puerto Rico. Cases are collected from over 1500 hospitals with CoC-accredited cancer programs [16] . Reporting centers consist of community hospitals, academic medical centers and NCI-designated Comprehensive Cancer Centers [17] . This study was reviewed and approved by the Institutional Review Board at University of Illinois at Chicago as exempt given the de-identified nature of the data.
NCDB dataset included 154,253 NHB and NHW women with stage-diagnosed invasive epithelial 1 OVCA between 1998 and 2011. In order to test hypotheses comparing NHB and NHW women, data were restricted to NHB and NHW women, with Hispanics and all others groups omitted. Only cases with complete data on stage were included, representing 11,562 NHB and 137,106 NHW. Cases were sequentially eliminated from analysis if they were younger than 20 years (n = 79, \0.1 %), because of differences in tumor behavior in young women, and if they reported having an ''unknown'' or ''other governmental health insurance'' (n = 5506, 3.6 %), as these categories were too small to analyze. In total, 26.6 % of cases; 34.0 % NHB and 26.0 % NHW had a registrydefined ''missing'' value for grade; these cases were not eliminated because of the important potential loss of information regarding the analytic sample. Data Standards (FORDS), using standardized data transmission procedures coordinated by the North American Association of Cancer Registries (NAACR) [18] . Briefly, diagnosis stage was based on FIGO categorization and defined by the pathologic stage group variable, which if missing, was then based on the clinical stage group. Diagnosis stage was analyzed as a dichotomous and also as a four level-category variable, respectively: early (stages I and II; localized) versus late (stages III and IV; regional and distant) and stages I, II, III and IV. The relationship between race and diagnosis stage was analyzed across three diagnosis periods (1998-2002, 2003-2007, 2008-2011) to assess temporal changes.
Variables
Zip code-level measures of income and education were estimated by matching the zip code of the patient recorded at the time of diagnosis against files derived from 2000 US Census data. They were analyzed according to NCDB-defined categories representing quartiles across all registry cancer cases [18] (i.e., OVCA cancer cases were skewed toward higher income; Table 1 ).
Age was analyzed in quartiles (\50, 50-64, 65-74, C75 years) [19] . Tumor grade was analyzed as a threelevel variable: (1) cell type well/moderately differentiated, (2) poorly differentiated/undifferentiated/anaplastic, (3) not determined/not stated/not applicable/unknown primaries/ high-grade dysplasia; and histology as a six-level variable (undifferentiated, unclassified, clear cell, endometrioid, serous and mucinous). Treatment facility case-volume was used as a proxy for surgeon experience [20] [21] [22] . It was defined using the average annual number of patients diagnosed with OVCA at each facility and analyzed in quartiles of case-volume (quartile distribution of cases per year: 1st = 0-7, 2nd = 8-16, 3rd = 17-28 and 4th C 29). Census-derived facility region was used as a proxy for healthcare access [12] .
For the purpose of this study, variables were classified into three groups: (1) tumor characteristics, including grade and histology, (2) socio-demographic, including age, education, income and health insurance and (3) institutional, including facility type, facility location and facility casevolume.
Statistical analyses
NHB-NHW differences in tumor characteristics, sociodemographic and institutional factors were assessed using Chi-square test statistics. Odds ratios (OR) and 95 % confidence intervals (95 % CI) were estimated using multivariable logistic regression. Four nested models were compared using the log-likelihood ratio test, adjusting for (1) age; (2) age, grade and histology; (3) previous covariates plus health insurance, income and education, (4) previous covariates plus facility type, facility location and facility case-volume. The total sample size was held constant across comparisons.
Effect modification in the final model between race and diagnosis period was assessed by including the pair-wise interaction term and the main effects. Interaction was marginally significant (p = 0.09); as such, diagnosis period-specific estimates were presented. The p trend was reported from the effect of diagnosis period on diagnosis stage in the final fully adjusted, non-stratified model.
The effect of race on different levels of the outcome variables (late stage vs. early, stage 4 vs. 1, stage 3 vs. 1 and stage 2 vs. 1) was estimated using multivariable generalized logit models, stratified by histology and grade. Effect modification was assessed between race and diagnosis stage.
Statistical significance was set to p \ 0.05 (two-sided), and all analyses were performed using SAS version 9.4 (SAS Institute, Inc., Cary, NC, USA). To rule out biases due to potential NHB-NHW differential case ascertainment over time, several sensitivity analyses were conducted. Sensitivity analyses were performed by estimating the adjusted OR and 95 % CI of NHB-NHW differences in late-stage diagnosis for each covariate category, stratified by diagnosis period. First, the temporal pattern (i.e., 1998-2002, 2003-2007, 2008-2011) of NHB-NHW differences in diagnosis stage was assessed across categorizations of each covariate (Table 3) . Second, temporal changes in NHB-NHW differences in case-volume across the nine US census regions were assessed. Third, temporal changes in NHB-NHW differences in diagnosis stage were compared across hospitals reporting different volumes of cases (0-100, 101-500, 501-1000, 1001-1500). Lastly, patient comorbidity collection began in 2003 and was not available to assess changes over the diagnosis periods, thus a second analysis stratified by the Charlson comorbidity index was conducted using the last two periods (i.e., [2003] [2004] [2005] [2006] [2007] [2008] [2009] [2010] [2011] ; Table 3 ).
Results
Analyses included 148,668 cases; 11,562 (7.8 %) NHB and 137,106 (92.2 %) NHW. Of these, late-stage disease (III, IV) was diagnosed in 76.3 % NHB and 70.1 % NHW (p \ 0.001). In bivariate analyses, NHB were more likely diagnosed with undifferentiated, unclassified or mucinous histologic subtypes when compared to NHW. In addition, NHB and NHW significantly differed in tumor characteristics, socio-demographic and institutional variables (Table 1) .
In comparison with the nested models (1998-2011), overall, NHB women were 1.26 (95 % CI 1.19-1.33) times more likely to be diagnosed with late-stage OVCA than (Fig. 1) . This pattern was consistent across all histologic subtypes. Effect modification to further explore what OVCA subtype is driving decreasing NHB-NHW stage differences over time demonstrated no statistically significant interaction between race and diagnosis period across the histologic subtypes. However, varying stage-specific NHB-NHW differences were present over time across the various subtypes (Fig. 1) .
No evidence of differential NHB-NHW case ascertainment was identified in sensitivity analyses (Table 3 ; results from all covariates presented), as is evident by comparing temporal patterns of NHB-NHW diagnostic stage differences across categorizations with each covariate. Additional sensitivity analyses indicated that excluding the comorbidity index, which was not collected prior to 2003 
Discussion
This study demonstrates that between 1998 and 2011, NHB are more likely diagnosed with late-stage invasive epithelial OVCA than NHW, after adjusting for potential confounders. The relationship between race and diagnosis stage is attenuated with the inclusion of tumor characteristics and demographic variables, but not institutional variables, in comparison with nested models. Findings also demonstrate that NHB-NHW stage differences decreased significantly across diagnosis periods. However, persisting NHB-NHW differences exist in the most recent period, with NHB significantly more likely diagnosed with latestage disease. These temporal changes confirm and extend the results from previous studies. After adjusting for appropriate confounders, NHB women were significantly more likely to be diagnosed with late-stage OVCA than NHW in analysis of the California Cancer Registry [13] and the Surveillance Epidemiology and End Results (SEER) data [14] . Our results also show that NHB women when compared to NHW are almost three times more likely to be diagnosed with stage 4 vs. stage 1 clear cell and mucinous carcinomas. In addition, they are 50 % more likely to be diagnosed with stage 4 vs. stage 1 high-grade serous carcinomas. Our analyses do not show any temporal changes in diagnosis stage over time in any of the histologic subtypes. To our knowledge, no other studies have assessed the effect of time on racial differences in OVCA diagnosis stage overall and by histologic subtypes.
Several potential reasons exist for these NHB-NHW stage difference findings, one of which is differential access to care. Previous literature suggests uninsured or underinsured patients are less likely to participate in cancer-screening programs [23] [24] [25] . Although no clearly established OVCA screening procedure is available, [26, 27] . According to the 2013 National Healthcare Disparity Report [28] , blacks have significantly worse healthcare access, are more likely to have communication difficulties with providers, in part to a mixed-race relationship between provider and patient [29] , are less likely to have a usual primary care provider, and are more likely to experience medical care delays for financial reasons [30] . Differences in quality of care [29] , medical mistrust [31] , timing [28] and healthcare access [31] may contribute to late-stage diagnoses. The reasons for the observed differential disparities in late-stage diagnosis across histologic subtype for NHB-NHW are unclear (e.g., the absence of differences with low-grade serous versus significant differences with clear cell), but likely represent a combination of dissimilarities between both groups in tumor biology, prevalence of subtype-specific risk factors, as well as the access-related issues discussed above. Documenting patterns in OVCA stage over time are an important surveillance activity, both in quantifying NHB-NHW stage differences and exploring factors that could explain observed differences. The decrease in racial differences in diagnosis stage over time identified may be attributed to factors such as improving healthcare access [32] . We hypothesize additional factors may account for the narrowing NHB-NHW stage differential observed over the study period, including improved delivery of care and doctor-patient relationships, decreased perceived racial discrimination and increased OVCA awareness.
Results should be interpreted in light of limitations. First, education and income variables were only available at the zip code level. While area-level socioeconomic status (SES) measures are proxies for individual-level SES, they are useful in assessing area-level health inequalities [33, 34] . Second, patient comorbidities were omitted from models as they were not collected prior to 2003. Comorbidities are influenced by healthcare access, such that women with comorbidities and healthcare access may have a higher chance of disease diagnosis [35] ; however, sensitivity analyses indicate such biases are unlikely. Third, although physician specialty, an important predictor for staging [31, 32] and OVCA cancer outcomes [19, [36] [37] [38] , was not available, we used average facility case-volume as a proxy to minimize this bias, as it has been demonstrated in multiple analyses that a low institutional case-volume reflects a lack of gynecologic oncology subspecialty care [20] [21] [22] . Fourth, although ORs may overestimate the relationship between race and diagnosis stage if the outcomes are highly prevalent, use of ORs is consistent with previous NCDB literature [12, 38] . Lastly, the NCDB does not include cases reported by non-approved hospitals, notably community hospitals serving minorities and women from lower SES groups, so results may be underestimated.
Despite limitations, several strengths exist. First, findings are likely the most accurate representation of racial differences in diagnosis stage across the USA, as this investigation approximates a population-based study by using NCDB, which is one of the largest dataset that includes 70 % of newly diagnosed OVCA cases in the USA and Puerto Rico [16, 17] . NCDB data are collected using nationally standardized definitions specified in FORDS and NAACR [18] . Although SEER has almost complete ascertainment among regions captured, it is limited to regions represented that include more urban areas with foreign-born people in comparison with the US 2010 population [39] , and it fails to consider highly segregated cities such as Chicago, Milwaukee and Philadelphia, which could mask racially patterned OVCA differences [40, 41] . Moreover, SEER only includes 28 % of the US population and does not collect data on health insurance [39, 42] . Second, results of this study are based on data obtained over 15 years. Notably, the long duration of follow-up allows for detailed comparisons and a temporal assessment of differences in NHB-NHW diagnosis stage, filling an important gap in the literature based on SEER data [43] . Third, the large sample size provides adequate study power to detect changes over time in NHB-NHW stage differences for OVCA in general and by histologic subtypes, with results generalizable to NHB and NHW diagnosed at CoC facilities in the USA and Puerto Rico. Additionally, the sample size was sufficient to allow multiple sensitivity analyses across various covariate categories, with results suggesting unlikely differential NHB-NHW case ascertainment.
In summary, results demonstrate that NHB are significantly more likely diagnosed with late-stage invasive epithelial OVCA than NHW, and more specifically, with high-grade serous, mucinous and clear cell carcinomas. Results also demonstrate an improvement in NHB-NHW stage differences over time. Documenting such patterns is an important surveillance activity for planning future healthcare needs, helping to quantify NHB-NHW stage differences and identify factors that are contributing to observed differences.
